Cargando…

New Insights into the Interaction between Graphene Oxide and Beta-Blockers

As a nano-adsorbent, magnetic graphene oxide (GO/Fe(3)O(4)) was synthesized to potentially adsorb propranolol (PRO) from water. The synthetic material was characterized by SEM, TEM, VSM, FTIR, XRD, zeta potential, and XPS. The environmental factors, such as pH, humic acid concentration, PRO concentr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yuehua, Li, Yani, Nie, Wenjie, Gao, Xiang, Liu, Shentan, Tan, Xiaochun, Chen, Mingming, Hou, Dongzhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835990/ https://www.ncbi.nlm.nih.gov/pubmed/31600918 http://dx.doi.org/10.3390/nano9101429

Ejemplares similares

Fast Removal of Propranolol from Water by Attapulgite/Graphene Oxide Magnetic Ternary Composites
por: Deng, Yuehua, et al.
Publicado: (2019)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers
por: Chahine, Mohamed
Publicado: (2011)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
por: Cojocariu, Sabina Alexandra, et al.
Publicado: (2021)

Topical beta‐blockers in dermatologic therapy
por: Filoni, Angela, et al.
Publicado: (2021)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study)
por: Glezer, Maria, et al.
Publicado: (2018)

The Impact of Beta Blockers on Survival in Heart Transplant Recipients: Insights from the Zabrze HTx Registry
por: Kubiak, Grzegorz M., et al.
Publicado: (2020)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

The evaluation of beta blocker and calcium antagonist drugs
Publicado: (1982)

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
por: Fitzgerald, Paul J
Publicado: (2012)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Oral Beta-blocker in Problematic Infantile Hemangioma
por: AlHasan, Rashed N., et al.
Publicado: (2021)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Effect of Beta-blockers on Extracranial Arteriovenous Malformations
por: CHASTANET, Sarah, et al.
Publicado: (2022)

Beta-Blockers in the Critically Ill: Friend or Foe?
por: Senussi, Mourad H.
Publicado: (2021)

Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022)

Beta Blocker-induced Recurrent Aphthous Stomatitis
por: Suda, Takuya, et al.
Publicado: (2022)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

Association between the beta‐blockers, calcium channel blockers, all‐cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta‐analysis of randomized controlled trials
por: Wu, Mingming, et al.
Publicado: (2023)

Co-adsorption of an anionic dye in the presence of a cationic dye and a heavy metal ion by graphene oxide and photoreduced graphene oxide
por: Zhang, Xiaorong, et al.
Publicado: (2019)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o1ie9oq6a0r7biqdj1a1g7fb81